ORGANIZATION
FIRM Unveils Vision 2030 to Bolster Japan’s Regenerative Medicine Industry
The Forum for Innovative Regenerative Medicine (FIRM) on July 14 unveiled its “FIRM Vision 2030,” setting out five strategic priorities through FY2030 aimed at accelerating the growth of regenerative medicines and cell and gene therapies in Japan. The roadmap calls…
To read the full story
ORGANIZATION
- PhRMA Slams CEA Expansion, Warns It Undermines Japan Growth Strategy
November 17, 2026
- UCB Japan President Kikuchi to Take Helm of EFPIA Japan
November 13, 2026
- Japan Pharmacy Group Renews Call to Scrap Off-Year Drug Price Revisions
November 13, 2026
- JPMA to Draw Up 2027 Strategic Plan Based on Industry Vision
November 13, 2026
- JMA Renews Backing for Hanako Jimi in 2028 Upper House Race
November 11, 2026
Tariffs have been a defining feature of US trade policy under President Donald Trump’s second administration. Since Trump unveiled his “reciprocal” tariff policy in April 2025, the landscape has shifted repeatedly.In February 2026, the US Supreme Court invalidated tariffs imposed…





